Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Daiichi Sankyo
McKesson
US Department of Justice
Deloitte
Chubb

Generated: September 19, 2019

DrugPatentWatch Database Preview

Patent: 10,143,752

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,143,752
Title:Methods of treating ulcerative colitis
Abstract: Methods for maintaining clinical remission of ulcerative colitis in a human patient are described comprising administration of an antibody that has binding specificity for human .alpha.4.beta.7 integrin using a safe dosing regimen of these antibody formulations that is easy to follow, and which results in a therapeutically effective amount of the anti-.alpha.4.beta.7 antibody in vivo.
Inventor(s): Fox; Irving H. (Wellesley, MA), Scholz; Catherine (Woburn, MA)
Assignee: Millennium Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:15/214,993
Patent Claims:see list of patent claims

Details for Patent 10,143,752

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Takeda Pharms Usa ENTYVIO vedolizumab INJECTABLE;INJECTION 125476 001 2014-05-20 ➤ Sign Up Millennium Pharmaceuticals, Inc. (Cambridge, MA) 2031-05-02 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Accenture
Moodys
Johnson and Johnson
Argus Health
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.